MENU
EWTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Edgewise Therapeutics (EWTX) Ownership - Who owns Edgewise Therapeutics?
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
1715 38th Street
Phone
+1 720 262-7002
Employees
88
Web
https://www.edgewisetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.33B
P/E Ratio
N/A
Total Cash
436.39M
Projected Growth
N/A
Total Debt
4.56M
Revenue
N/A
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
4.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
EWTX
Capitalization
1.33B
P/E Ratio
N/A
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash
436M
Total Cash/Share
4.15
Total Debt
4.56M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
430M
P/B Ratio
2.27
Cash Flow
N/A
Earnings
-1.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
20.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-167.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.98
Shares Held By Institutions
2.95B
Shares Outstanding - Current
105M
Total Liabilities
24.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-52.509
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EWTX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1715 38th Street
Phone
+1 720 262-7002
Employees
88
Web
https://www.edgewisetx.com